Adaptate Biotherapeutics

Adaptate is a biotechnology company which spun-out from GammaDelta Therapeutics in 2019. Adaptate is focused on developing therapeutic antibodies to drug targets to modulate the activity of gamma delta T cells. The company has received investment from Abingworth and Takeda Pharmaceutical Company, with support from King's College London, the Francis Crick Institute and Cancer Research Technology
Social Link - Linkedin: http://www. linkedin.com/company /adaptate
Employee Count: 5
Keywords: biotechnology research